Minimizing Legal Risks: Common Labelling Pitfalls and How to Avoid Them

In the food and cosmetics industry, the product label serves as a consumer-facing communication tool and a legal document. It is the first point of contact between a product and the authorities, so it is the main source of exposure to legal risks. Whether through misleading information, non-authorised claims, or errors in presentation, a non-compliant label can result in several consequences such as enforcement actions that affect not only a single batch but an entire brand’s reputation, market access, and profitability. Regulatory compliance in labelling is a critical safeguard against both regulatory and commercial fallout.

Frequent Labelling Mistakes That Lead to Legal Trouble

Ironically, the most common labelling pitfalls are also the most avoidable. Yet time and again, companies, especially those expanding into new markets or launching new products, overlook essential requirements or make assumptions based on prior market practices that no longer hold.

One of the leading causes of non-compliance in food supplements and nutraceuticals is the use of unapproved or unsubstantiated health claims. In the EU, Regulation (EC) No 1924/2006 strictly governs the conditions under which nutrition and health claims can be made. Only claims authorized and listed in the EU Register of Health Claims may be used, and they must be worded exactly as approved. Claims such as "boosts immunity" or "reduces inflammation" are routinely flagged by enforcement bodies if the claim lacks specific scientific backing, or if it implies a medicinal benefit.

Another frequent issue lies in the inaccurate declaration of serving sizes or daily recommended intakes. This becomes particularly problematic in cross-border trade, where national tolerances or consumer usage habits differ. Serving sizes that do not reflect actual consumption patterns can mislead consumers and distort the calculated intake of key nutrients or active ingredients. This is particularly sensitive in products targeting children, pregnant women, or individuals with health conditions.

Formatting issues also contribute to non-compliance. For example, failure to respect minimum font sizes, omission of mandatory information such as allergen declarations, or lack of language adaptation to the target market can result in product recalls, even if the product composition is fully compliant. These errors are not simply technical. Depending on the impact, they can be construed as violations of consumer protection law or unfair competition, triggering broader legal consequences.

Enforcement Actions Reflect Regulatory Priorities

Recent enforcement cases highlight a growing regulatory appetite to crack down on misleading labelling. In 2023 alone, several EU member states reported joint surveillance actions under the European Commission’s Coordinated Control Plan, focusing on online sales of food supplements. A notable outcome was the detection of over 250 non-compliant listings, with the most common violations being unauthorised claims and omission of legally required warnings or instructions for use.

In the United States, the Food and Drug Administration (FDA) continues to issue warning letters to companies marketing dietary supplements with claims that the agency deems to be drug-like. In one recent case, a company promoting a turmeric-based product as "effective against arthritis and joint pain" was issued a warning letter and ordered to cease sales until the labelling and marketing practices could be corrected.

Fines and recalls are not the only risks. In the cosmetics sector, class action lawsuits have emerged in markets like the US and Canada, where consumer protection laws enable litigation over misleading natural or organic claims. Even in jurisdictions where the regulatory framework is less prescriptive, consumer watchdog groups and competitors may use misleading labelling as grounds for complaints, triggering investigations or court actions.

The financial impact of such enforcement can be substantial. Beyond the cost of product withdrawal or relabelling, companies may face legal fees, reputational damage, and distribution partner terminations. For small and mid-sized enterprises, a single enforcement event can be enough to disrupt cash flow or market entry.

Building Compliance Into Labelling Workflows

Avoiding these pitfalls begins with building a robust, cross-functional labelling approval process. At its core, this involves the alignment of regulatory affairs, marketing, legal, and scientific functions from the earliest stage of product development.

A well-structured internal review system will typically include multiple verification points. These should assess not only the accuracy of ingredient lists, nutritional values, and usage instructions, but also the appropriateness of claims, the completeness of mandatory labelling elements, and the legal acceptability of any optional elements such as graphics, colours, or quality seals.

Compliance checklists tailored to product category and market of sale are essential. These should reference the latest applicable regulations, such as Regulation (EU) No 1169/2011 for food information to consumers, the EU Cosmetics Regulation (1223/2009), or regional guidelines for botanical health claims. When developing for multiple jurisdictions, dual review systems may be needed to ensure both baseline and local-specific compliance.

Another best practice is the implementation of controlled labelling templates that reduce free-text entry and enforce standard terminology. Such templates can be built into digital label management systems or controlled document workflows to ensure traceability and consistency.

Ongoing Vigilance: Label Audits and Documentation

Regulatory compliance is not static. As scientific understanding evolves and as regulations are amended or reinterpreted, labels that were once compliant can quickly become outdated. This is particularly true in dynamic sectors such as novel foods, CBD-containing products, or high-risk nutraceuticals where regulatory positions remain fluid.

Regular label audits should be scheduled as part of a company’s quality management system. These audits should not only re-check compliance with existing legal texts, but also scan for changes in enforcement trends, guidance updates, or evolving interpretations by authorities or courts.

Maintaining clear documentation is another critical element of risk management. Every label version should be archived, along with its date of use, the responsible reviewer’s sign-off, and references to the legal basis for each claim or labelling element. This traceability becomes essential in the event of a challenge, allowing the company to demonstrate due diligence and defend its rationale.

For companies operating across multiple product lines or markets, centralised labelling databases with version control, language variants, and country-specific rules can greatly streamline operations and reduce risk. Ideally, these systems should integrate with product lifecycle management and regulatory intelligence tools, ensuring that label changes trigger necessary updates across packaging, promotional materials, and online listings.

The Strategic Value of Getting It Right

Investing in labelling compliance goes beyond risk avoidance. A compliant label builds trust. It signals transparency, accountability, and a respect for consumer rights and safety. In many regulated markets, such as the EU, labelling compliance is also a prerequisite for product registration, market access, and even eligibility for retail distribution or advertising.

Retailers, distributors, and online platforms are increasingly proactive in requiring suppliers to demonstrate compliance. One of the world’s largest online retailers, for instance, now mandates documentation for dietary supplement labels sold in several EU countries, including Certificate of Analysis, pictures of the packaging, and proof that the product complies with applicable legislation. In this environment, compliance is a competitive advantage, opening doors that might otherwise remain closed.

Finally, when enforcement happens, as it inevitably will for even the most compliant companies, a strong labelling history and demonstrable internal controls can mean the difference between a minor correction and a full-blown product crisis. Regulatory authorities are more likely to work constructively with companies that can show their efforts at compliance were genuine, thorough, and well-documented.

Final Thoughts on Labelling Risk Management

Labelling errors may appear small on the surface, but their implications can be wide-ranging and costly. Missteps in serving size, formatting, or omission of critical details can expose companies to legal sanctions, consumer backlash, and loss of market trust. With clear systems for internal review, ongoing audits, and proper documentation, these risks can be significantly reduced.

In an industry where product differentiation often hinges on what appears on the package, the pressure to push marketing boundaries will always exist. But it is precisely in this space, between innovation and compliance, where well-informed, strategically cautious decisions must be made. Labels that align with both legal frameworks and consumer understanding are essential for sustainable commercial success.